Patents-Review.com
ClassID:

21066 ⎘

A61K39/0012 - CPC Classification

Classification description:

Medicinal preparations containing antigens or antibodies; Vertebrate antigens Lipids; Lipoproteins

Recent Application in this class:
#1
20260130978
2026-05-14

Ultrapurified Phospholipoproteomic Composition for High-Purity Biomolecular Research and Precision Therapeutics

 #2
20250213665
2025-07-03

METHODS FOR INHIBITING TRAINED IMMUNITY WITH NANOBIOLOGIC COMPOSITIONS

 #3
20250170179
2025-05-29

VACCINE COMPRISING NATURAL KILLER CELLS LOADED WITH LIGANDS OF NATURAL KILLER T CELLS AND CANCER ANTIGENS

 #4
20250041407
2025-02-06

VARICELLA ZOSTER VIRUS (VZV) VACCINE

 #5
20250025544
2025-01-23

IMMUNE CHECKPOINT INHIBITOR CO-EXPRESSION VECTORS

 #6
20250018029
2025-01-16

METHODS TO ALTER THE TUMOR MICROENVIRONMENT FOR EFFECTIVE CANCER IMMUNOTHERAPY

 #7
20240398865
2024-12-05

TUMOR AVATAR VACCINE COMPOSITIONS AND USES THEREOF

 #8
20240156960
2024-05-16

SYSTEMS AND METHODS FOR EXPRESSING BIOMOLECULES IN A SUBJECT

 #9
20240108716
2024-04-04

MONOVALENT AND MULTIVALENT VACCINES FOR PREVENTION AND TREATMENT OF DISEASE

 #10
20230210971
2023-07-06

EDIBLE PLANT EXOSOME-LIKE NANOVECTORS FOR VACCINATION

 #11
20230052399
2023-02-16

METHODS TO ALTER THE TUMOR MICROENVIRONMENT FOR EFFECTIVE CANCER IMMUNOTHERAPY

 #12
20220409720
2022-12-29

Varicella zoster virus (VZV) vaccine

 #13
20220409708
2022-12-29

SMALL LIPID NANOPARTICLES, AND CANCER VACCINE INCLUDING SAME

 #14
20220195013
2022-06-23

MULTI-EPITOPIC CONSTRUCT

 #15
20210338789
2021-11-04

COMPOSITIONS AND METHODS FOR MODIFIED DENDRIMER NANOPARTICLE DELIVERY

 #16
20210236612
2021-08-05

EDIBLE PLANT EXOSOME-LIKE NANOVECTORS FOR VACCINATION

 #17
20210213122
2021-07-15

IMMUNE CHECKPOINT INHIBITOR CO-EXPRESSION VECTORS

 #18
20200397891
2020-12-24

Compositions and methods for reducing serum triglycerides

 #19
20200376102
2020-12-03

METHODS FOR INHIBITING TRAINED IMMUNITY WITH NANOBIOLOGIC COMPOSITIONS

 #20
20200171138
2020-06-04

VIRUS LIKE PARTICLE WITH EFFICIENT EPITOPE DISPLAY

 #21
20200155660
2020-05-21

COMPOSITIONS AND METHODS FOR MODIFIED DENDRIMER NANOPARTICLE DELIVERY

 #22
20200069793
2020-03-05

Varicella zoster virus (VZV) vaccine

 #23
20190307704
2019-10-10

METHOD FOR ENHANCED DELIVERY OF GENE BASED THERAPY AND VACCINATION USING ELECTROPORATION

 #24
20190307703
2019-10-10

MULTI-FUNCTIONAL NANOPARTICLES FOR VACCINATION

 #25
20190204337
2019-07-04

Saposin lipoprotein particles and libraries from crude membranes

 #26
20190022206
2019-01-24

Virus like particle with efficient epitope display

 #27
20180311340
2018-11-01

NEW ADJUVANT AND VACCINE COMPOSITION CONTAINING THE SAME

 #28
20180273608
2018-09-27

Multi-epitopic construct

 #29
20180221475
2018-08-09

METHODS TO ALTER THE TUMOR MICROENVIRONMENT FOR EFFECTIVE CANCER IMMUNOTHERAPY

 #30
20180043015
2018-02-15

Methods for diagnosing and reducing incidences of cardiac allograft rejection

 #31
20170273905
2017-09-28

Lipid membrane structure for intracellular delivery of siRNA

 #32
20170100432
2017-04-13

ANTIGEN SPECIFIC TOLEROGENIC ANTIGEN PRESENTING CELLS AND RELATED USES COMPOSITIONS, METHODS AND SYSTEMS

 #33
20170079916
2017-03-23

Compositions and methods for modified dendrimer nanoparticle delivery

 #34
20170072037
2017-03-16

Xenoantigen-displaying anti-cancer vaccines and method of making

 #35
20160303211
2016-10-20

DNA vaccine containing specific epitope of apolipoprotein (a)

 #36
20160106822
2016-04-21

PCSK9 peptide combination vaccine and method of use

 #37
20160067322
2016-03-10

METHOD OF TREATING LUNG CANCER BY VACCINATION WITH MUC-1 LIPOPEPTIDE

 #38
20150233941
2015-08-20

Substances, vaccines and methods for diagnosing and reducing incidences of transplant rejection

 #39
20150209293
2015-07-30

Peptide conjugated particles for the treatment of allergy

 #40
20150071990
2015-03-12

Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine

 #41
20150071951
2015-03-12

PCSK9 peptide combination vaccine and method of use

 #42
20150024037
2015-01-22

Xenoantigen-Displaying Anti-Cancer Vaccines and Method of Making

 #43
20140356367
2014-12-04

Monophosphorylated lipid A derivatives

 #44
20140308306
2014-10-16

Methods for treating kidney disease with fragments of ApoB-100

 #45
20140086949
2014-03-27

Ghrelin mimetic polypeptide hapten immunoconjugates having improved solubility and immunogenicity and methods of use thereof

 #46
20140086944
2014-03-27

DNA VACCINE CONTAINING SPECIFIC EPITOPE OF APOLIPOPROTEIN (a)

 #47
20140044734
2014-02-13

Methods for treating liver inflammation in a subject suffering from non-alcoholic steatohepatitis

 #48
20130236418
2013-09-12

Immunomodulatory methods and systems for treatment and/or prevention of aneurysms

 #49
20130230487
2013-09-05

Immunomodulatory methods and systems for treatment and/or prevention of hypertension

 #50
20120311729
2012-12-06

Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis

 #51
20120251513
2012-10-04

Antigen Specific Tolerogenic Antigen Presenting Cells and Related Uses Compositions, Methods and Systems

 #52
20110275556
2011-11-10

Treatment of atherosclerosis with cholesterol ester transport protein mimotopes

 #53
20110262526
2011-10-27

METHOD OF INDUCING AN ANTI-VIRAL IMMUNE RESPONSE

 #54
20100278907
2010-11-04

Immunogenic Compositions Containing Ceramide and Methods of Use Thereof

 #55
20100266623
2010-10-21

SYNTHETIC, SELF ADJUVANTING VACCINES

 #56
20090208503
2009-08-20

IMMUNOTHERAPEUTIC TREATMENT

 #57
20090148460
2009-06-11

EXOSOME LIGANDS, THEIR PREPARATION AND USES

 #58
20090142362
2009-06-04

Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (CETP)

 #59
20090092618
2009-04-09

PEPTIDE-BASED IMMUNIZATION THERAPY FOR TREATMENT OF ATHEROSCLEROSIS

 #60
20080311152
2008-12-18

Modulation of developmental immune programming and protection against cardiovascular disease, diabetes, infectious diseases, and cancer

 #61
20080070265
2008-03-20

PEPTIDE-BASED IMMUNIZATION THERAPY FOR TREATMENT OF ATHEROSCLEROSIS

 #62
20070231344
2007-10-04

Conjugate vaccines for non-proteinaceous antigens

 #63
20070122419
2007-05-31

Methods and compositions for treating atherosclerosis

 #64
20070110770
2007-05-17

Apolipoprotein E as an adjuvant for lipid antigens

 #65
20070014844
2007-01-18

Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine

 #66
20060233817
2006-10-19

Peptide-based immunization therapy for treatment of atherosclerosis

 #67
20050197308
2005-09-08

Vaccines

 #68
15615753
2020-06-30

Reversibly crosslinked endosomolytic polymer vesicles for cytosolic drug delivery